Ralf Pasternack Zedira managing partner    Ralf Pasternack was born on November 4th, 1967 in Wiesbaden, Germany.
He studied Chemistry at the Technical University Darmstadt and received his Diploma in Biochemistry in 1994 working in the group of Prof. H.G. Gassen. In 1998 he obtained his PhD working on Microbial Transglutaminase from Streptomyces together with Prof. H.-L. Fuchsbauer & Prof. H.G. Gassen.
Together with both supervisors and Dr. Jochen Klein (former CEO of the Doehler Group) he founded his first core Biotech company called N-Zyme BioTec and served as CEO. In 2007 he co-founded Zedira by a management buyout and holds the function of a CEO. The company specializes on therapeutic and diagnostic applications of transglutaminase.
  • News  

    • Press release: Dr. Falk Pharma and Zedira announce completion of phase 1b clinical trial of ZED1227 for the treatment of celiac disease and move on to proof of concept study
    • Pressemitteilung: Dr. Falk Pharma und Zedira geben den Abschluss der Phase 1b-Studie für ZED1227 zur Zöliakie-Therapie bekannt und planen Start der Wirksamkeitsstudie
  • Blog

  • Events  

    • 17th International Celiac Disease Symposium

      08.09.2017 - 10.09.2017
      New Delhi, India

    • NLSDays 2017

      12.09.2017 - 14.09.2017
      Malmö, Sweden

    • BIO-Europe

      06.11.2017 - 08.11.2017
      Berlin, Germany

    • MEDICA

      13.11.2017 - 16.11.2017
      Düsseldorf, Germany

    • Gordon Research Conference on: Transglutaminases in Human Disease Processes

      16.06.2018 - 17.06.2018
      Les Diablerets, Switzerland